Details
Stereochemistry | ACHIRAL |
Molecular Formula | C24H26N2O6 |
Molecular Weight | 438.473 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCOC1=C(OC)C=CC2=C1NC(=O)C(=C2)C(=O)NCC3=CC=C4OCOC4=C3
InChI
InChIKey=GRAJFFFXJYFVOC-UHFFFAOYSA-N
InChI=1S/C24H26N2O6/c1-3-4-5-10-30-22-19(29-2)9-7-16-12-17(24(28)26-21(16)22)23(27)25-13-15-6-8-18-20(11-15)32-14-31-18/h6-9,11-12H,3-5,10,13-14H2,1-2H3,(H,25,27)(H,26,28)
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/11160626Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/24445310 | https://www.ncbi.nlm.nih.gov/pubmed/16824511
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11160626
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/24445310 | https://www.ncbi.nlm.nih.gov/pubmed/16824511
JTE-907 is selective high-affinity cannabinoid CB2 receptor inverse agonist. JTE-907 showed a concentration-dependent increase of forskolin-stimulated cAMP production in CHO cells expressing human and mouse CB2 in vitro. In mice model of atopic dermatitis, JTE-907 suppresses spontaneous itch-associated responses of NC mice without adverse effects such as weight loss.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL253 Sources: https://www.ncbi.nlm.nih.gov/pubmed/16539390 |
25.1 nM [IC50] | ||
Target ID: CHEMBL218 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24445310 |
2370.0 nM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Characterization of anandamide-stimulated cannabinoid receptor signaling in human ULTR myometrial smooth muscle cells. | 2009 Sep |
|
Cannabinoid agonists increase the interaction between β-Arrestin 2 and ERK1/2 and upregulate β-Arrestin 2 and 5-HT(2A) receptors. | 2013 Feb |
|
Cannabinoid receptor agonists upregulate and enhance serotonin 2A (5-HT(2A)) receptor activity via ERK1/2 signaling. | 2013 Mar |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16824511
The anti-pruritic activity of JTE-907 was studied in NC mice: 1 and 10 mg/kg/day for 20 days
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11160626
CHO cells expressing CB receptors were harvested and cultured at a density of 1 3 10^4 cells/well in 96-well culture plate. After 24-h culture at 37°C, cells were washed with phosphatebuffered saline and incubated at 37°C for 10 min in HEPES buffer [137 mM NaCl, 4.5 mM KCl, 1.2 mM MgCl2, 1 mM CaCl2 x 2H2O, 20 mM HEPES, and 10 mM D-(+)-glucose at pH 7.4] containing 0.25 mM Ro20-1724 in the presence or absence of JTE-907 (0.1nM-100mkM). Cells were then incubated with 5 mM forskolin at 37°C for 15 min, followed by the addition of ice-cold 2.5% dodecyltrimethylammonium bromide (Amersham Pharmacia Biotech, Piscataway, NJ) to stop the reaction. The wells were agitated for 60 min at room temperature. cAMP concentration in the medium of each well was measured by enzyme immunoassay kit
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-JTE-907
Created by
admin on Sat Dec 16 19:36:13 GMT 2023 , Edited by admin on Sat Dec 16 19:36:13 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DAV3Q7SNOL
Created by
admin on Sat Dec 16 19:36:13 GMT 2023 , Edited by admin on Sat Dec 16 19:36:13 GMT 2023
|
PRIMARY | |||
|
DTXSID00101001
Created by
admin on Sat Dec 16 19:36:13 GMT 2023 , Edited by admin on Sat Dec 16 19:36:13 GMT 2023
|
PRIMARY | |||
|
282089-49-0
Created by
admin on Sat Dec 16 19:36:13 GMT 2023 , Edited by admin on Sat Dec 16 19:36:13 GMT 2023
|
PRIMARY | |||
|
JTE-907
Created by
admin on Sat Dec 16 19:36:13 GMT 2023 , Edited by admin on Sat Dec 16 19:36:13 GMT 2023
|
PRIMARY | |||
|
9867770
Created by
admin on Sat Dec 16 19:36:13 GMT 2023 , Edited by admin on Sat Dec 16 19:36:13 GMT 2023
|
PRIMARY |
ACTIVE MOIETY